本页面由Tiger Trade Technology Pte. Ltd.提供服务

Editas Medicine, Inc.

1.77
-0.0550-3.01%
盘后:1.810.0400+2.26%19:51 EST
成交量:199.06万
成交额:365.92万
市值:2.73亿
市盈率:-2.86
高:1.95
开:1.86
低:1.76
收:1.83
52周最高:3.94
52周最低:1.66
股本:1.54亿
流通股本:1.16亿
量比:0.77
换手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-0.6180
每股收益(LYR):-1.8036
净资产收益率:-147.44%
总资产收益率:-24.69%
市净率:3.23
市盈率(LYR):-0.98

数据加载中...

2026/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/09

重要事件披露

Form 8-K - Current report
2026/10/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/08

重要事件披露

Form 8-K - Current report
2026/09/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/02

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report